Drug Availability

HPS Pharmacies wish to give notice that Pfizer Australia is experiencing a supply constraint for Edronax® tablets as follows:

Edronax® 4mg Tablets 
Reboxetine 4mg
ARTG 79745

This supply constraint is due to a delay in supply from the manufacturing facility. There are no safety concerns with this product. While wholesaler stocks of Edronax® are currently restricted, HPS Pharmacies can still source a limited supply for the benefit of our clients. Normal supplies are expected to resume in mid-May 2018.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 999 543.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates